The U.S. Securities and Exchange Commission (SEC) has issued a concept release seeking public comment on potential changes to the definition and eligibility criteria of Foreign Private Issuers (FPIs). The proposed modifications could result in fewer foreign companies qualifying as FPIs, impacting their regulatory reporting requirements. This initiative is part of a broader review of the foreign private issuer regulatory framework. Concurrently, the SEC and the Commodity Futures Trading Commission (CFTC) have extended the compliance deadline for amendments to Form PF, which imposes new data reporting requirements on investment advisers to private funds. The extension was granted just one day before the original deadline, reflecting ongoing reconsideration of the rules. In related legal developments, patent lawyers are adjusting strategies for drafting and defending drug-device patents following a recent court ruling affecting the FDA's registry used by brand-name companies to protect against generic competition.